ActiveAtlas Opportunity Score 82/100
NYSDOH-IFB-20792-VACCINE-SUPPLYNew YorkNew York State Department of HealthHealthcare ProviderHealthcare Procurement & ContractsImmunization & Vaccine AccessPublic Health Infrastructure
New York State Vaccine Program Supply — IFB #20792
New York State Department of Health is soliciting qualified vaccine suppliers for one or more five-year contracts supporting the Vaccines for Children and Vaccines for Adults programs. Amendment #1 extends bids to September 25, 2026 at 5:00 PM ET.
FundingNo fixed contract ceiling or guaranteed order minimum is stated. Awarded vendors must price vaccines at no more than the current CDC cost per dose; actual order quantities may vary, and the IFB states that no annual or order minimums are guaranteed.
DeadlineSeptember 25, 2026 at 5:00 PM ET under Amendment #1. Written questions are due September 4, 2026 at 5:00 PM ET, with responses expected on or about September 11, 2026.
Last verifiedAugust 31, 2026
Required next actionQualified vaccine suppliers should review IFB #20792 and Amendment #1, confirm at least three years of experience supplying CDC-listed vaccines and at least three years of cold-chain vaccine distribution experience, complete the application and bid forms, price eligible vaccines at or below the current CDC cost per dose, and submit the complete bid by September 25, 2026 at 5:00 PM ET.
Broad Eligibility
Bidders must have at least three years of experience as a prime contractor providing vaccines listed on the CDC vaccine list and at least three years of experience handling and distributing vaccine under cold-chain requirements, including temperature monitoring. The Department intends to award one or more five-year contracts covering vaccines for pediatric and adult state vaccine-eligible populations. Subcontractors may not be proposed.
Atlas Analysis
A material statewide vaccine-supply procurement supporting New York's Vaccines for Children and Vaccines for Adults programs. The opportunity is commercially meaningful for established vaccine manufacturers/distributors but is highly specialized. N9+ Direct Vendor Fit is 0/100 because the procurement is exclusively for FDA-approved vaccine supply and distribution and does not provide a defensible N9+ hardware, telehealth, RPM or clinical-services pathway. Amendment #1 controls the revised September 25 bid deadline.
Source verificationOfficial government source · www.health.ny.govAtlas last verified this record August 31, 2026. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗